Table 2. Folate and vitamin B12 markers in plasma before and after 2 years of intervention in the MRI subgroup.
Placebo group | Active treatment groupa | |||||||
N | Geometric mean | 95% C.I. | N | Geometric mean | 95% C.I. | P value b | ||
tHcy | Before | 83 | 11.27 | (10.58–12.00) | 85 | 11.25 | (10.58–11.97) | 0.974 |
(µmol/L) | After | 83 | 12.14 | (11.40–12.93) | 84 | 8.72 | (8.29–9.17) | <0.001 |
P value c | <0.001 | <0.001 | ||||||
Folate (nmol/L) | Before | 83 | 24.2 | (21.4–27.5) | 85 | 22.4 | (19.4–25.9) | 0.428 |
After | 83 | 24.9 | (21.4–29.1) | 84 | 82.1 | (74.6–90.4) | <0.001 | |
P value c | 0.695 | <0.001 | ||||||
Vitamin B12 (pmol/L) | Before | 83 | 333 | (310–357) | 85 | 330 | (303–360) | 0.891 |
After | 83 | 366 | (335–400) | 84 | 672 | (626–722) | <0.001 | |
P value c | 0.018 | <0.001 | ||||||
HoloTC (pmol/L) | Before | 83 | 68 | (61–76) | 85 | 63 | (55–72) | 0.406 |
After | 83 | 73 | (65–82) | 84 | 182 | (162–204) | <0.001 | |
P value c | 0.116 | <0.001 | ||||||
TC saturation (%) | Before | 83 | 7.35 | (6.54–8.25) | 85 | 6.65 | (5.72–7.73) | 0.306 |
After | 83 | 7.17 | (6.26–8.21) | 84 | 20.42 | (18.21–22.90) | <0.001 | |
P value c | 0.648 | <0.001 | ||||||
Cystathionine | Before | 83 | 0.303 | (0.273–0.337) | 85 | 0.265 | (0.237–0.295) | 0.082 |
(µmol/L) | After | 83 | 0.350 | (0.311–0.395) | 84 | 0.215 | (0.196–0.235) | <0.001 |
P value c | 0.002 | <0.001 |
Abbreviations: HoloTC, holotranscobalamin; TC saturation, ratio of holoTC to total TC; tHcy, plasma total homocysteine.
Active treatment group received daily supplements of folic acid (0.8 mg), vitamin B12 (0.5 mg) and vitamin B6 (20 mg) for 24 months.
Student's t-test for unpaired samples,
Student's t-test for paired samples.